ImmunityBio Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for ImmunityBio stock have an average target of 11.35, with a low estimate of 4.75 and a high estimate of 30. The average target predicts an increase of 280.23% from the current stock price of 2.99.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$4.75	$11.35	$8.00	$30
Change	+59.13%	+280.23%	+168.01%	+905.03%

Analyst Ratings

The average analyst rating for ImmunityBio stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	1	1	1	2	2	4
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	3	3	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $30	Strong Buy	Maintains	$30	+905.03%	Mar 31, 2025
Andres Maldonado HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $8	Strong Buy	Reiterates	$8	+168.01%	Mar 13, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $30	Strong Buy	Maintains	$30	+905.03%	Mar 13, 2025
Andrew Fein HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $8	Strong Buy	Initiates	$8	+168.01%	Mar 6, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $30	Strong Buy	Maintains	$30	+905.03%	Mar 3, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

106.39M

from 14.75M

621.53%

from 14.75M

Revenue Next Year

280.41M

from 106.39M

163.57%

from 106.39M

EPS This Year

-0.51

from -0.62

EPS Next Year

-0.34

from -0.51

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	605.00K	934.00K	240.00K	622.00K	14.75M	106.39M	280.41M	720.53M
Revenue Growth	-72.52%	54.38%	-74.30%	159.17%	2,270.58%	621.53%	163.57%	156.96%
EPS	-0.59	-0.89	-1.04	-1.15	-0.62	-0.51	-0.34	0.08
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	38.17
No. Analysts	-	-	-	-	-	7	6	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	127.9M	353.1M	1.3B
Avg	106.4M	280.4M	720.5M
Low	83.7M	181.7M	353.1M

Revenue Growth

Revenue Growth	2025	2026	2027
High	767.3%	231.9%	349.0%
Avg	621.5%	163.6%	157.0%
Low	467.5%	70.7%	25.9%

EPS Forecast

EPS	2025	2026	2027
High	-0.44	-0.33	0.54
Avg	-0.51	-0.34	0.08
Low	-0.57	-0.35	-0.17

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.